94
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Analysis of the Financial Impact of Using Cangrelor on the Safety and Efficacy Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Whom Oral Therapy with P2Y12 Inhibitors is Not Feasible or Desirable, in Spain

Pages 77-87 | Published online: 27 Jan 2021